RT Book, Section
A1 Granwehr, Bruno P.
A1 Kontoyiannis, Dimitrios P.
A2 Kantarjian, Hagop M.
A2 Wolff, Robert A.
A2 Rieber, Alyssa G.
SR Print(0)
ID 1190839554
T1 Fungal Infections in Patients with Cancer
T2 The MD Anderson Manual of Medical Oncology, 4e
YR 2022
FD 2022
PB McGraw Hill Education
PP New York, NY
SN 9781260467642
LK accessmedicine.mhmedical.com/content.aspx?aid=1190839554
RD 2024/04/25
AB KEY  CONCEPTSFungal  infections  are  common  in  patients  with  cancer.Morbidity  and  mortality  associated  with  fungal  infection  complicate  cancer  treatment  outcomes.Invasive  candidiasis  is  the  most  common  fungal  infection  in  patients  with  cancer,  requiring  careful  assessment  for  dissemination,  selection  of  appropriate  antifungal  agent,  removal  of  infected  devices,  and  duration  of  therapy.Invasive  aspergillosis  (IA)  is  the  most  common  mold  infection  in  patients  with  cancer,  requiring  vigilance  to  detect  pulmonary  or  sinus  infection,  which  may  require  resection  or  debridement  in  addition  to  aggressive  antifungal  therapy.Rare  molds  that  infect  patients  with  cancer  include  Fusarium  and  Mucorales  spp.,  typically  affecting  patients  with  hematologic  malignancy,  with  recovery  of  neutrophils  the  most  important  factor  in  improving  mortality.